Abstract
EEC syndrome is an autosomal dominant disorder characterized by ectrodactyly, ectodermal dysplasia, and facial clefts. We have mapped the genetic defect in several EEC syndrome families to a region of chromosome 3q27 previously implicated in the EEC-like disorder, limb mammary syndrome (LMS). Analysis of the p63 gene, a homolog of p53 located in the critical LMS/EEC interval, revealed heterozygous mutations in nine unrelated EEC families. Eight mutations result in amino acid substitutions that are predicted to abolish the DNA binding capacity of p63. The ninth is a frameshift mutation that affects the p63alpha, but not p63beta and p63gamma isotypes. Transactivation studies with these mutant p63 isotypes provide a molecular explanation for the dominant character of p63 mutations in EEC syndrome.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Abnormalities, Multiple / genetics*
-
Amino Acid Sequence
-
Amino Acid Substitution
-
Chromosome Mapping
-
Chromosomes, Human, Pair 3*
-
DNA-Binding Proteins
-
Ectodermal Dysplasia / genetics
-
Face / abnormalities
-
Female
-
Foot Deformities, Congenital / genetics
-
Genes, Tumor Suppressor*
-
Genes, p53*
-
Genetic Markers
-
Germ-Line Mutation*
-
Hand Deformities, Congenital / genetics
-
Humans
-
Male
-
Membrane Proteins*
-
Models, Molecular
-
Molecular Sequence Data
-
Mutation, Missense*
-
Pedigree
-
Phosphoproteins / chemistry
-
Phosphoproteins / genetics*
-
Protein Structure, Secondary
-
Sequence Alignment
-
Sequence Homology, Amino Acid
-
Syndrome
-
Trans-Activators*
-
Transcription Factors
-
Tumor Suppressor Proteins
Substances
-
CKAP4 protein, human
-
DNA-Binding Proteins
-
Genetic Markers
-
Membrane Proteins
-
Phosphoproteins
-
TP63 protein, human
-
Trans-Activators
-
Transcription Factors
-
Tumor Suppressor Proteins